Extraction, GC-MS analysis, cytotoxic, anti-inflammatory and anticancer potential of Cannabis sativa female flower; in vitro, in vivo and in silico
Frontiers in Pharmacology · 11.02.2025 · 16
DOI: 10.3389/fphar.2025.1546062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 11.02.2025. Verfasst von Waqas Safir und 4 weiteren Autor:innen. Beteiligte Einrichtung: Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Sciences and Technology, Xinjiang University, Urumqi, Xinjia…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This work examines the anticancer activity, the anti-inflammatory nature, and the cytotoxicity of the ethanol extract obtained from the female flowers of Cannabis sativa L using molecular methods in vitro , animal testing in vivo , as well as computational methods and simulations in silico . From the GC-MS analysis, the following bioactive compounds were found: cannabidiol (CBD), tetrahydrocannabinol (THC), and humulene. The antiproliferative activities of the extract were determined on HeLa cells by using MTT, Crystal Violet, and Trypan Blue assays with an IC50 value suggesting 51%-77.6% lethality. The bioinformatics analysis of molecular docking proved significant ligand-protein interactions of CBD, THC, and humulene with cancer-associated proteins such as PD-1/PD-L1, TNF-α, and MMP-9. In vivo , breast cancer was first established in female Sprague-Dawley rats with 7,12-dimethylbenz(a)anthracene (DMBA) then treated with cannabinoids either singularly or in combination. Detailed treatment demonstrated that the use of the three cannabinoids simultaneously yielded the best anticancer and anti-inflammatory outcomes together with the best tumor reduction. The concentration of serum biomarkers of inflammation and tumor progression was substantially reduced in treated groups compared to the control group, which proves the synergistic effects of these cannabinoids in breast cancer therapy. This study emphasizes the importance of medical Cannabis sativa derivatives in cancer treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Sciences and Technology, Xinjiang University, Urumqi, Xinjiang, China.
- School of Pain and Regenerative Medicine (SPRM), The University of Lahore, Lahore, Pakistan.
- Faculty of Health Sciences, Equator University of Science and Technology, (EQUSaT), Masaka, Uganda.
- Department of Biochemistry, Islam Medical College, Sialkot, Pakistan.
Zitieren
APA
Safir, W., Malik, A., Saadia, H., Zahid, A., & Li, J. (2025). Extraction, GC-MS analysis, cytotoxic, anti-inflammatory and anticancer potential of Cannabis sativa female flower; in vitro, in vivo and in silico. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1546062
Vancouver
Safir W, Malik A, Saadia H, Zahid A, Li J. Extraction, GC-MS analysis, cytotoxic, anti-inflammatory and anticancer potential of Cannabis sativa female flower; in vitro, in vivo and in silico. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1546062
BibTeX
@article{Safir2025,
author = {Safir, Waqas and Malik, Arif and Saadia, Haleema and Zahid, Ayesha and Li, Jinyao},
title = {Extraction, GC-MS analysis, cytotoxic, anti-inflammatory and anticancer potential of Cannabis sativa female flower; in vitro, in vivo and in silico},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1546062}
}
EUVIMED